Should all diabetic ketoacidosis be treated the same?
Top line: Sodium-glucose cotransporter 2 inhibitor (SGLT2i)-associated diabetic ketoacidosis (DKA) in patients with type 2 diabetes (T2D) is characterized by a degree of hyperglycemia during the first 24 hours of…